A bid by the Trump administration to shine light on the high costs of prescription drugs prompted legal resistance Friday by three major pharmaceutical companies.
Amgen, Eli Lilly, and Merck sued the Department of Health and Human Services in a bid to block new rules requiring that companies disclose the “list price’’ of their drugs in television advertising.
